BiotechTube

Famotidine FCT + Famotidine CT

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Aug 1, 2006 → Sep 1, 2006

NCT ID
NCT00945750

About Famotidine FCT + Famotidine CT

Famotidine FCT + Famotidine CT is a phase 1 stage product being developed by Merck for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00945750. Target conditions include Heartburn.

What happened to similar drugs?

7 of 15 similar drugs in Heartburn were approved

Approved (7) Terminated (0) Active (8)
✅esomeprazole 40 mgAstraZenecaApproved
✅Esomeprazole magnesium (Nexium)AstraZenecaApproved
✅Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
✅Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
✅Esomeprazole 20 mg + PlaceboPfizerApproved
✅Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
✅Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00945750Phase 1Completed

Competing Products

20 competing products in Heartburn

See all competitors
ProductCompanyStageHype Score
rabeprazole sodiumEisaiPhase 3
40
rabeprazole sodium + placeboEisaiPhase 3
40
Rabeprazole sodiumEisaiPre-clinical
26
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
29
esomeprazole 40 mgAstraZenecaApproved
43
Esomeprazole magnesium (Nexium)AstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
43
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
43
LanzoprazoleNovartisPhase 3
40
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
40
LansoprazoleNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + PlaceboNovartisPhase 2
35
Esomeprazole 20 mg + PlaceboPfizerApproved
43
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)BayerPhase 1
26
omeprazole/sodium bicarbonate + omeprazole magnesiumBayerPhase 1
26
Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
40
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
40